AU2003205963A1 - Azaphenylalanine derivatives and their use as antithrombotic agents - Google Patents

Azaphenylalanine derivatives and their use as antithrombotic agents

Info

Publication number: AU2003205963A1
Authority: AU; Australia
Prior art keywords: azaphenylalanine; derivatives; antithrombotic agents; antithrombotic; agents
Prior art date: 2002-01-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003205963A

Other versions

AU2003205963A8 (en

Inventor

Ales Obreza

Mojca Stegnar

Alenka Trampus Bakija

Uros Urleb

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Lek Pharmaceuticals dd

Univerza Ljubljana v Fakulteta za Farmazijo

Original Assignee

Lek Pharmaceuticals dd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-24

Filing date

2003-01-27

Publication date

2004-08-23

2003-01-27 Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd

2004-08-23 Publication of AU2003205963A8 publication Critical patent/AU2003205963A8/en

2004-08-23 Publication of AU2003205963A1 publication Critical patent/AU2003205963A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
- C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003205963A 2002-01-24 2003-01-27 Azaphenylalanine derivatives and their use as antithrombotic agents Abandoned AU2003205963A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SI200200013A SI21137A (en)	2002-01-24	2002-01-24	Derivatives of azaphenyl-alanine
PCT/IB2003/000403 WO2004067522A1 (en)	2002-01-24	2003-01-27	Azaphenylalanine derivatives and their use as antithrombotic agents

Publications (2)

Publication Number	Publication Date
AU2003205963A8 AU2003205963A8 (en)	2004-08-23
AU2003205963A1 true AU2003205963A1 (en)	2004-08-23

Family

ID=39522234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003205963A Abandoned AU2003205963A1 (en)	2002-01-24	2003-01-27	Azaphenylalanine derivatives and their use as antithrombotic agents

Country Status (6)

Country	Link
AT (1)	AT503355A2 (en)
AU (1)	AU2003205963A1 (en)
CH (1)	CH696724A5 (en)
DE (1)	DE10392134T5 (en)
SI (1)	SI21137A (en)
WO (1)	WO2004067522A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005297610B2 (en) *	2004-10-14	2011-05-19	Wilex Ag	Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid
DE102004057195A1 (en) *	2004-11-26	2006-06-01	Wilex Ag	Crystalline modifications of N-alpha (2,4,6-triisopropylphenylsulfonyl) -3-hydroxyamidino- (L) -phenylalanine-4-ethoxycarbonylpiperazide and / or salts thereof
GB0523539D0 (en) *	2005-11-18	2005-12-28	Lek Tovarna Farmacevtskih	New use of organic compounds
AU2008235089B8 (en)	2007-04-10	2014-04-10	Bayer Intellectual Property Gmbh	Insecticidal aryl isoxazoline derivatives
CA3131772A1 (en)	2019-02-28	2020-09-03	Fujifilm Corporation	Method for producing peptide compound, protecting group-forming reagent, and condensed polycyclic aromatic hydrocarbon compound
CA3131774A1 (en)	2019-02-28	2020-09-03	Fujifilm Corporation	Method for producing peptide compound, protecting group-forming reagent, and aromatic heterocyclic compound
WO2020262258A1 (en) *	2019-06-28	2020-12-30	富士フイルム株式会社	Method for producing peptide compound, reagent for forming protecting group, and condensed polycyclic aromatic hydrocarbon compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992008709A1 (en) *	1990-11-15	1992-05-29	Pentapharm Ag	Meta-substituted phenyl alanine derivatives
DE4111394A1 (en) *	1991-04-09	1992-10-15	Behringwerke Ag	AMIDINOPHENYLALANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AND MEANS THEREOF
GB9322976D0 (en) *	1993-11-08	1994-01-05	Pfizer Ltd	Therapeutic agents
WO2002074756A2 (en) *	2001-03-21	2002-09-26	Pentapharm Ag	Urokinase inhibitors

2002
- 2002-01-24 SI SI200200013A patent/SI21137A/en not_active IP Right Cessation
2003
- 2003-01-27 DE DE10392134T patent/DE10392134T5/en not_active Withdrawn
- 2003-01-27 CH CH01209/04A patent/CH696724A5/en not_active IP Right Cessation
- 2003-01-27 AU AU2003205963A patent/AU2003205963A1/en not_active Abandoned
- 2003-01-27 AT AT0900103A patent/AT503355A2/en not_active Application Discontinuation
- 2003-01-27 WO PCT/IB2003/000403 patent/WO2004067522A1/en not_active Ceased

Also Published As

Publication number	Publication date
AT503355A2 (en)	2007-09-15
CH696724A5 (en)	2007-10-31
AU2003205963A8 (en)	2004-08-23
WO2004067522A1 (en)	2004-08-12
DE10392134T5 (en)	2005-10-13
SI21137A (en)	2003-08-31

Publication	Publication Date	Title
AU2003266321A1 (en)	2004-04-08	Tetrahydropyrimidine-2-one derivatives and their uses
TWI349671B (en)	2011-10-01	Novel adenine derivative and its use
AP2004003110A0 (en)	2004-09-30	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AU2003249909A1 (en)	2004-01-19	Phenoxypropenylphenyl derivatives and their use as herbicides
AU2003235676A1 (en)	2003-07-30	Tricyclic-bis-enone derivatives and methods of use thereof
AU2003295551A1 (en)	2004-06-15	Wiping articles and their use
AU2003241833A1 (en)	2003-12-12	Beta-ALANINE DERIVATIVE AND USE THEREOF
AU2003303388A1 (en)	2004-07-22	Triptolide derivatives and their use
AU2003281044A1 (en)	2004-02-02	Pyrrolopyridine derivative and use thereof
IL163868A0 (en)	2005-12-18	Hermiasterlin derivatives and uses thereof
AU2003292422A1 (en)	2004-07-14	Oxazolidinone derivatives and their use as antibacterial agents
AU2003244836A1 (en)	2004-03-11	Suspending agent
AU2003216221A1 (en)	2003-09-04	Attachment and articles using same
AU2003269197A1 (en)	2004-04-23	Microbicidal compositions and their use
AU2003292381A1 (en)	2004-07-14	Naphthyridine derivatives and their use as fungicides
AU2003205558A1 (en)	2003-09-09	Thioibotenic acid and derivatives thereof
AU2003274351A1 (en)	2004-06-18	Substituted pyridyloxyalkylamides and their use as fungicides
AU2003208707A1 (en)	2003-09-29	Benzyl alcohol derivatives and their use as antimicrobial agents
AU2003297612A1 (en)	2004-06-23	2-substituted-3-propenamide derivatives and methods of using the same
AU2003303678A1 (en)	2004-08-10	Urea derivatives and their use as anti-inflammatory agents
AU2003205963A1 (en)	2004-08-23	Azaphenylalanine derivatives and their use as antithrombotic agents
AU2003252684A1 (en)	2004-05-04	N-acetylglucosamine derivatives and use thereof
AU2003281691A1 (en)	2004-02-16	Furoisoquinoline derivative and use thereof
AU2003206872A1 (en)	2003-09-04	Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
AU2003900495A0 (en)	2003-02-20	Aroylhydrazone derivatives and therapeutic uses thereof

Legal Events

Date	Code	Title	Description
2005-08-18	TH	Corrigenda	Free format text: IN VOL 18, NO 37, PAGE(S) 9225 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME LEK PHARMACEUTICALS D.D., APPLICATION NO. 2003205963, UNDER INID (71) CORRECT THE NAME TO READ LEK PHARMACEUTICALS D.D.; UNIVERSITY OF LJUBLJANA
2005-10-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase